Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


UK Reveals Plan To Improve Access To Safe New Medicines

Ideas Include Reduced Regulatory Burden, Working With HTA Bodies

Executive Summary

The three-year Delivery Plan just unveiled by the UK medicines agency is part of its aim to create a “new era” in drug regulation.

You may also be interested in...

UK Promises RWD Guidance In Plan To Boost Trial Innovation

The UK medicines regulator has published a new plan to deliver on several short-term projects as it tries to keep pace with the fast-moving life sciences sector and the needs of patients. 

How To Navigate Northern Ireland's Complex Regulatory Landscape

A TOPRA webinar gave UK-based pharma firms an idea of the complexities and uncertainties they will need to deal with when placing medicines on the market in different parts of the UK.

Stakeholders To Have Say On Future Medicines Verification System In UK

The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts